Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent Deferred RevenueGoodwillGoodwill & IntangiblesLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios

Metlife (MET-PF) Payables (2016 - 2025)

Metlife has reported Payables over the past 17 years, most recently at $355.0 million for Q4 2025.

  • Quarterly results put Payables at $355.0 million for Q4 2025, down 23.66% from a year ago — trailing twelve months through Dec 2025 was $355.0 million (down 23.66% YoY), and the annual figure for FY2025 was $355.0 million, down 23.66%.
  • Payables for Q4 2025 was $355.0 million at Metlife, down from $378.0 million in the prior quarter.
  • Over the last five years, Payables for MET-PF hit a ceiling of $465.0 million in Q4 2024 and a floor of $119.0 million in Q4 2023.
  • Median Payables over the past 5 years was $332.0 million (2021), compared with a mean of $289.3 million.
  • Biggest five-year swings in Payables: crashed 50.13% in 2022 and later surged 290.76% in 2024.
  • Metlife's Payables stood at $341.0 million in 2021, then crashed by 48.68% to $175.0 million in 2022, then plummeted by 32.0% to $119.0 million in 2023, then surged by 290.76% to $465.0 million in 2024, then fell by 23.66% to $355.0 million in 2025.
  • The last three reported values for Payables were $355.0 million (Q4 2025), $378.0 million (Q3 2025), and $379.0 million (Q2 2025) per Business Quant data.